An observational study in Dyslipidemia, sponsored by Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo. Completed at 1 site in Mexico. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-18.
Sponsored by Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo · Observational
Traditional cardiovascular risk models are limited in capturing functional alterations in HDL-C linked to smoking and diet in Latin American populations. We analyzed the relationship between traditional and non-traditional risk factors and the serum lipid profile of hospitalized Mexican adults, emphasizing HDL-C behavior.
An analytical, cross-sectional study was conducted in 70 adults following the STROBE statement. Non-parametric tests, Huber's robust multiple regression, and structural equation modeling (SEM) were performed.
1,247 studies on the registry are indexed under Dyslipidemias; 175 are open to participants now.
This study's enrollment of 107 is below the median of 648 across 229 observational studies indexed under Dyslipidemias.
Browse Dyslipidemias studies →Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Hospitalized mexican adults
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Male and female, above 18 years of age, except patients with cognitive impairment or inability to provide informed consent, those with acute conditions that could alter the lipid profile, and those for whom a laboratory sample could not be obtained.
Measure serum lipid profile (total cholesterol, HDL-C, LDL-C, triglycerides, VLDL-C)
Differences in serum lipid concentrations (mg/dL) according to traditional and non-traditional cardiovascular risk factors, with emphasis on HDL-C as an indirect marker of antiatherogenic dysfunction
Time frame: Baseline
Measure HDL-C concentration by smoking status
Comparison of HDL-C levels between active smokers and non-smokers
Time frame: Baseline
Measure Triglyceride and VLDL-C levels in patients with diabetes mellitus
Comparison of triglyceride and VLDL-C concentrations by diabetes mellitus diagnosis
Time frame: Baseline
Measure HDL-C levels by ultraprocessed beverage consumption
Association between self-reported ultraprocessed beverage intake and HDL-C concentration
Time frame: Baseline
Identify anthropometric predictors of lipid profile
Contribution of weight, height, and BMI to each lipid variable via multiple regression and structural equation models
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo